Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
REPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CENPBD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RPS15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VDR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MID1IP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTP4A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CGGBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RPS17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TARP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XRCC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPPL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUFY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on